Our study, as well as the one by Boutros et al,18 showed that biologically aggressive variants of breast cancer, such as grade III, HER2-enriched (or triple-negative tumors) were not predictive of metastasis at initial presentation. Here, ERBB2 is linked to breast carcinoma.